Advances in the Management of Relapsing Multiple Sclerosis

EP. 1: The Etiology of Multiple Sclerosis

March 6th 2020

EP. 2: A Redefined Classification of Multiple Sclerosis

March 6th 2020

EP. 3: Implications of Revised McDonald Criteria in MS

March 6th 2020

EP. 4: Magnetic Resonance Imaging in Multiple Sclerosis

March 6th 2020

EP. 5: Optimizing Treatment Selection in Multiple Sclerosis

March 6th 2020

EP. 6: First-Line Therapy for Multiple Sclerosis

March 6th 2020

EP. 7: Siponimod for Relapsing MS

March 6th 2020

EP. 8: Treating Forms of MS With Ocrelizumab

March 6th 2020

EP. 9: Recent Treatment Strategies Explored for Relapsing MS

March 6th 2020

EP. 10: Switching Therapy for Relapsing MS

March 6th 2020

EP. 11: Addressing Limitations in the Management of MS

March 6th 2020

EP. 12: Multiple Sclerosis in the Community: Best Practices

March 6th 2020

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG

FDA Grants Fast Track Status to FRP-003 for Long COVID Ahead of Phase 2 Study

T-Cell Engager Cizutamig Shows Early Efficacy Signal in Generalized Myasthenia Gravis

New CTE Prevalence Estimate Underscores Push for Diagnosis Living Patients

Headlining Current Advances and Challenges in Multiple Sclerosis Care